Target
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
Ligand
BDBM650840
Substrate
n/a
Meas. Tech.
In vitro Assay (1 nM)
IC50
1.10±n/a nM
Citation
 Markowitz, SAntczak, MReady, JZhang, Y COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY US Patent  US20240043440 Publication Date 2/8/2024 
Target
Name:
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
Synonyms:
15-PGDH | 15-hydroxyprostaglandin dehydrogenase [NAD+] | HPGD | PGDH1 | PGDH_HUMAN | Prostaglandin dehydrogenase 1 (15-PGDH) | SDR36C1
Type:
Enzyme
Mol. Mass.:
28974.46
Organism:
Human
Description:
P15428
Residue:
266
Sequence:
MHVNGKVALVTGAAQGIGRAFAEALLLKGAKVALVDWNLEAGVQCKAALDEQFEPQKTLFIQCDVADQQQLRDTFRKVVDHFGRLDILVNNAGVNNEKNWEKTLQINLVSVISGTYLGLDYMSKQNGGEGGIIINMSSLAGLMPVAQQPVYCASKHGIVGFTRSAALAANLMNSGVRLNAICPGFVNTAILESIEKEENMGQYIEYKDHIKDMIKYYGILDPPLIANGLITLIEDDALNGAIMKITTSKGIHFQDYDTTPFQAKTQ
  
Inhibitor
Name:
BDBM650840
Synonyms:
US20240043440, Example 47
Type:
Small organic molecule
Emp. Form.:
C21H20N4OS2
Mol. Mass.:
408.54
SMILES:
CCCCS(=O)c1sc2nc(cc(-c3ccccc3)c2c1N)-c1ccncn1
Structure:
Search PDB for entries with ligand similarity: